Article

Current progress and future perspectives in the development of anti-polo-like kinase 1 therapeutic agents

2017-06-29

Abstract excerpt

Although significant levels of side effects are often associated with their use, microtubule-directed agents that primarily target fast-growing mitotic cells have been considered to be some of the most effective anti-cancer therapeutics. With the hope of developing new-generation anti-mitotic agents with reduced side effects and enhanced tumor specificity, researchers have targeted various proteins whose functions...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 40e964e1-6034-560d-86f2-5542dd23ce5c
DOI: 10.12688/f1000research.11398.1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Current progress and future perspectives in the development of anti-polo-like kinase 1 therapeutic agentsDOI 10.12688/f1000research.11398.1Read

Polo-Like Kinase (PLK) Inhibitors in Preclinical and Early Clinical Development in OncologySemantic proximity Read

Polo-like kinase inhibitors: an emerging opportunity for cancer therapeuticsSemantic proximity Read

Targeting Polo-like Kinase in Cancer TherapySemantic proximity Read

Polo-like Kinase 1 as an emerging drug target: structure, function and therapeutic implicationsSemantic proximity Read

PLK-1 Targeted Inhibitors and Their Potential against TumorigenesisSemantic proximity Read

A review of Plks: Thinking outside the (polo) boxSemantic proximity Read

Present and Future Perspective on PLK1 Inhibition in Cancer TreatmentSemantic proximity Read

Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer TreatmentSemantic proximity Read

The balance of Polo-like kinase 1 in tumorigenesisSemantic proximity Read

Polo-Like Kinases (Plks), a Key Regulator of Cell Cycle and New Potential Target for Cancer TherapySemantic proximity Read

The Mitotic Cancer Target Polo-Like Kinase 1: Oncogene or Tumor Suppressor?Semantic proximity Read

Thoughts on the current assessment of Polo-like kinase inhibitor drug discoverySemantic proximity Read